H.R. 8251, titled “The HCT/P Modernization Act of 2024,” aims to simplify the regulation of human cell and tissue products in the U.S. The bill instructs the Secretary of Health and Human Services to provide clear and timely guidance on regulatory classifications and calls for a public...
Simple Explanation
H.R. 8251 wants to make it easier and faster for special medical products made from human cells and tissues to be approved, by giving clear guidelines and having meetings to get people's opinions. It also wants regular updates to the rules and reports to the government to keep everything on track.